http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-2935255-T1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53810094575edc7546de6511f90fa6b0 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-00 |
filingDate | 2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ac51b9161d9a747211da7548d72526 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27375a3db0b0ea2b09e9f839877398f0 |
publicationDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SI-2935255-T1 |
titleOfInvention | PROCEDURE FOR PREPARATION OF RIVAROKSABAN |
abstract | The present invention relates to rivaroxaban, more particularly to a process for preparation of rivaroxaban characterized in that the (S) -4- (4- (5- (aminomethyl ) -2-oxooxazolidin-3 yl) phenyl) morpholin-3-one hydrochloride is reacted with 5-chlorothiophene-2-carbonyl chloride in a reaction medium which comprises 1-methylimidazole, to new polymorphic form K and to a process of its crystallization. |
priorityDate | 2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.